Introduction Directory UMM :Data Elmu:jurnal:P:PlantScience:PlantScience_Elsevier:Vol156.Issue1.2000:

Plant Science 156 2000 55 – 63 Glycosylation of the cationic peanut peroxidase gene expressed in transgenic tobacco Bao Lige a , Shengwu Ma b , Robert B. van Huystee a, a Department of Plant Sciences, Uni6ersity of Western Ontario, London, Ont., Canada N 6 A 5 B 7 b Siebens-Drake Research Institute, 1400 Western Road, London, Ont., Canada N 6 G 2 V 4 Received 19 August 1999; received in revised form 22 February 2000; accepted 22 February 2000 Abstract The major cationic peanut Arachis hypogaea peroxidase, secreted into the extracellular space, is a glycoprotein with three N-linked glycans polysaccharides which are connected to the peptide backbone at Asn-60, Asn-144 and Asn-185. In this report, a C-terminal histidine-tagged cationic peanut peroxidase gene was expressed in transgenic tobacco Nicotiana tabacum. Tissue of the transgenic tobacco was cultured in suspension culture and the his-tagged peroxidase was purified in large quantities from 14-day-old suspension culture. The number of glycans, glycosylation sites and the chemical nature of glycan moieties attached to cationic peanut peroxidase expressed in transgenic tobacco were examined. Cationic peanut peroxidase isolated from the above transgenic tobacco had the identical number of complex glycans, attached at the same glycosylation sites as on cationic peanut peroxidase isolated from peanut suspension culture. Monosaccharide components of these glycans are N-acetylglucosamine GlcNAc, mannose Man, fucose Fuc, xylose Xyl and galactose Gal, the same sugars as found in native cationic peanut peroxidase. © 2000 Elsevier Science Ireland Ltd. All rights reserved. Keywords : Peroxidase; Peanut; N-linked glycans; Monosaccharide; Glycosylation; Transgenic tobacco www.elsevier.comlocateplantsci

1. Introduction

Glycosylation is one of the most important co- and post-translational modifications to proteins. Proteins, including plant proteins can be glycosy- lated at either O- or N-glycan binding sites, as reviewed [1 – 4]. Many functions have been sug- gested for protein glycosylation, including sig- nalling for intracellular targeting, protection from proteolytic breakdown, maintenance of protein stability, configuration and correct folding [5 – 9]. Proteins are direct gene products. Therefore, their sequences are determined by a template. In glycan biosynthesis, no such template is involved in the processing of the oligosaccharides. More- over, the biosynthesis of complex N-linked glycans can be affected by various environmental factors [6]. Therefore, glycoproteins may not always be similarly glycosylated when comparisons are made between different cell types from the same organ- ism [6,10,11]. Thus, if a glycoprotein is expressed in foreign host cells, its glycosylation could be very different from the original glycoprotein [12,13], and these modifications may alter the biological activity of a protein. In addition, the same oligosaccharide on different proteins may have quite different properties, depending on the orien- tation with respect to its polypeptide [7]. The sequence and linkage of each of the monosaccha- ride components and the mature oligosaccharide structure at a specific glycosylation site are compli- Abbre6iations : ABEE, p-aminobenzoic ethyl ester; CM, car- boxymethylcellulose; cPrx, cationic peanut peroxidase; cPrx-his6, six histidine-tagged cationic peanut peroxidase; Fuc, fucose; Gal, galac- tose; GlcN, glucosamine; GlcNAc, N-acetylglucosamine; Man, man- nose; NTA, nitrilotriacetic acid; PVDF membrane, polyvinylidene difluoride membrane; TFA, trifluoroacetic acid; TPCK, L -1-tosy- lamido-2-phenylethylchloromethyl ketone; Xyl, xylose. Corresponding author. Tel.: + 1-519-6792111, ext. 6490; fax: + 1-519-6613935. E-mail address : huysteejulian.uwo.ca R.B. van Huystee 0168-945200 - see front matter © 2000 Elsevier Science Ireland Ltd. All rights reserved. PII: S 0 1 6 8 - 9 4 5 2 0 0 0 0 2 3 3 - 8 cated [14] and many factors may be involved. We are interested in understanding the role of glycosy- lation in the action and formation of cationic peanut peroxidase cPrx. cPrx, a 40-kDa protein, is the major secreted isozyme of peanut peroxidases [15]. Like many plant extracellular proteins, cPrx is also an intensively studied glycoprotein with three N-linked glycans which are connected to the polypeptide backbone at Asn-60, Asn-144 and Asn- 185 [16]. While the function of heme and calcium in the enzyme are now known [17], little if anything is known about the role of the glycans [18]. The glycans belong to the complex type and sugar composition analysis shows that N-acetylglu- cosamine GlcNAc, mannose Man, fucose Fuc, galactose Gal and xylose Xyl are present in all three glycans [19], in agreement with its structure [14]. The cPrx is synthesised as a pre-protein con- taining a 22-amino acid N-terminal signal peptide [20]. When its cDNA was expressed in transgenic tobacco, the signal peptide of cPrx was able to direct the secretion of cPrx into the extracellular space [21]. As a first step towards the analysis of the biological role of glycans in the function of cPrx, a C-terminal histidine-tagged cPrx gene was ex- pressed in transgenic tobacco and purified in large quantities from the tobacco cell suspension culture. Then, the number of glycans, glycosylation sites and the chemical nature of carbohydrate moieties at- tached to cPrx expressed in transgenic tobacco were examined. 2. Materials and methods 2 . 1 . Genetic manipulation and production of transgenic plants For Agrobacterium-mediated transformation, a binary plasmid was assembled as shown in Fig. 1. A portion was designed to include the full length of cPrx coding gene sequence with its N-terminal signal peptide facilitating secretion into extracellu- lar medium, plus the codons for C-terminal six consecutive histidine residues. The latter was added so as to form a recombinant protein permitting simple identification and purification. The strategy and procedure for DNA manipulation, analysis of transgenic expression and localization were com- pleted as described [21]. 2 . 2 . Production of transgenic tobacco callus suspension culture For the establishment of callus suspension cul- ture, leaf discs from young transformed plants known to be expressing cPrx were cultured on agar plates of callus inducing medium supplemented with 250 mgml of carbenicilin and 100 mgml of kanamycin as described [21]. After 5 – 6 weeks, suspension cultures were initiated in 250 ml liquid callus inducing medium containing 50 mgml of kanamycin from the developed calli at 25°C with continuous shaking 120 rpm and maintained for 4 – 6 weeks until uniform dividing cell cultures had been established. Large scale cell cultures were started by expanding the culture from the continu- ously established cell suspension in 250 ml medium. The cells were grown in same but antibiotic-free liquid medium at room temperature with continu- ous shaking 140 rpm, and were routinely subcul- tured every 7 days by adding 250 ml of fresh medium to 250 ml of 14-day-old cell culture grown in 500 ml medium in an 1000-ml flask. 2 . 3 . Purification of the expressed protein from the spent medium The 14-day-old spent culture medium was sepa- rated from the tobacco cells by vacuum filtration and subsequently the macromolecular components in the medium were precipitated in 70 acetone at 4°C overnight. The precipitate was centrifuged at 9000 × g for 15 min, and the pellet was resuspended in 20 mM Na-acetate buffer pH 5.0. Fig. 1. Schematic representation of the construction part of cPrx-his expression vector. cPrx coding sequence with its N-terminal signal peptide and the codons for C-terminal histidine-tag was placed under the control of double 35S promoter with a TEV leader sequence. This construct was then inserted into the binary vector plasmid [21] facilitating the transfer of the chimeric gene into tobacco cells. NOS-ter, nopaline synthase terminator; NPTII, neomycin phospho- transferase II gene; TEV leader, leader sequence of tobacco etch virus. After removing the insolubles by centrifugation at 10 000 × g, the supernatant was brought to 80 saturated ammonium sulphate and cen- trifuged at 13 000 × g for 10 min. The pellet was resolubilized in 20mM Na-acetate buffer pH 5.0, then dialysed against double distilled water overnight at 4°C, and the flocculated material which appeared during dialysis was removed by centrifugation at 13 000 × g [15]. The dialysate was placed on a 2 × 15-cm car- boxymethylcellulose CM BioRad column pre- equilibrated with 20 mM Na-acetate buffer pH 5.0, and intensively washed with 20 mM Na-ac- etate buffer pH 5.0 to remove the unbound proteins. Then, a continuous gradient from 20 to 300 mM Na-acetate buffer pH 5.0 was used to elute the bound protein. The CM column was regenerated with 1 M Na-acetate buffer pH 5.0 and re-equilibrated with 20 mM Na-acetate buffer pH 5.0 [19]. The eluate from the gradient of 20 – 300 mM was precipitated in 70 acetone at − 20°C. The pellet from centrifugation at 13 000 × g was air dried and resuspended in 10 mM imidazole pH 7.0. Then, the protein solution was loaded on a 1.5 × 15-cm column of Ni 2 + -nitrilotriacetic acid NTA resin pre-equilibrated with 10 mM imida- zole pH 7.0. Prior to elution, the bound mate- rial was washed extensively with 30 mM imidazole pH 6.3 to remove the non-specifically bound proteins. The bound protein was eluted with 300 mM imidazole pH 5.0 [21]. The eluate was precipitated in 70 acetone at − 20°C overnight and the pellet from centrifugation at 13 000 × g was air dried, and resuspended in 1 mM NH 4 -acetate pH 5.0 for analysis. The column was regenerated with 600 mM imidazole pH 5.0 and re-equilibrated with 10 mM imida- zole pH 7.0. The purity of six histidine-tagged cationic peanut peroxidase cPrx-his6 was exam- ined by SDS-PAGE [22] and measuring the RZ value. 2 . 4 . Trypsin digestion and gel filtration chromatography The purified cPrx-his6 30 mg was treated with acidic acetone 0.5 HCl in pure acetone, vv to remove its heme component as described [23]. Then the mixture was centrifuged at 13 000 × g for 15 min and the pelleted protein was resuspended in 3 ml of 0.1 M NH 4 HCO 3 buffer pH 8.0. If any reddish color remained, the acidic acetone treatment was repeated until all heme moiety was completely removed. The apoprotein was collected by centrifugation, then air dried and resuspended in 3 – 4 ml of 0.1 M NH 4 HCO 3 buffer pH 8.0, and digested with L - 1-tosylamido-2-phenylethylchloromethyl ketone- TPCK treated trypsin 2 mgml, trypsin dis- solved in 0.1 M NH 4 HCO 3 buffer, pH 8.0 sub- strate:enzyme = 30:1, ww [16] at 37°C for 2 h. Then the tryptic peptides were loaded on a Bio- Gel P-6 column 1.5 × 90 cm, molecular weight range 1000 – 6000 Da, 50 – 150 mesh pre-equili- brated with 0.1 M NH 4 HCO 3 buffer pH 7.0. The same buffer was also used as a mobile phase, and the elution was carried out at room temperature, at a flow rate of 8 mlh. Glycopep- tide-containing fractions were identified using a modified phenol sulphuric acid method and col- lected. In this method, 50 ml of sample was mixed with 50 ml of 5 phenol in a clear 1.5-ml microtube, and 400 ml of pure sulphuric acid was added. The color of the reaction solution was observed 15 min later [24]. The fractions con- taining glycopeptides were then dialysed against HPLC grade distilled water and lyophilized for further analysis. 2 . 5 . Separation of glycopeptides by re6erse phase HPLC The lyophilized glycopeptides were resolubi- lized in 500 ml HPLC grade deionized water, and injected onto a C-18 column Jupiter 250 × 4.60 mm, Phenomenex connected to a HPLC system gold apparatus programmable solvent module 126, Beckman and a Rheodyne injector with a 500-ml sample loop. Elution was performed at room temperature at a flow rate of 1.2 mlmin in an acetonitrile gradient for 60 min 0 – 5 min, 0.1 trifluoroacetic acid TFA; 5 – 10 min, 0 – 20 acetonitrile; 10 – 35 min, 20 – 25 acetoni- trile; 35 – 50 min, 25 – 45 acetonitrile; 50 – 60 min, 45 – 100 acetonitrile. The peptide elution profile was detected at 230 nm, and the glycan- containing fractions were identified using the modified phenol-sulphuric acid method as de- scribed above. The carbohydrate containing frac- tions were pooled accordingly, dialysed against HPLC grade distilled water, and lyophilized. 2 . 6 . Identification of glycopeptides by N-terminal sequence analysis The three glycopeptides separated by HPLC were loaded on SDS-gel electrophoresis, respec- tively, and then transferred onto polyvinylidene difluoride PVDF membranes BioRad. Follow- ing staining with Coomassie blue, the peptide bands were cut out, destained in 40 methanol, and sequenced on an Applied Biosystem Model 475 sequencing apparatus equipped with an on- line model 120A HPLC for phenylthiohydatoin amino acid identification. 2 . 7 . Labelling of sugars with p-aminobenzoic ethyl ester ABEE The preparation of ABEE reagent and the derivatization of sugars were completed as de- scribed [19]. To prepare the stock for ABEE reagent, 330 mg ABEE and 70 mg sodium cyanoborohydride were dissolved in 700 ml methanol, and then 82 ml glacial acetic acid was added. The stock was stored at 4°C. Before use, the ABEE reagent was warmed to 25°C to dissolve any crystals formed during storage. To derivatize standard sugars, 80 ml of ABEE reagent was added to aliquots of 20 ml of different concentrations of standard sugars containing 800 nmol lactose. Lactose was used as an internal standard and derivatized along with other sugars. Following a brief vortexing, the mixture was incu- bated in a heating block at 80°C for 55 min. Then 380 ml HPLC grade distilled water was added to the reaction vials and mixed by vortexing. Chloro- form 1 ml was added to the mixture and vor- texed vigorously to extract the free ABEE reagent. The chloroform and aqueous phase were separated by placing the vials on the bench or by brief centrifugation and the chloroform lower phase was carefully removed by pipette. The chloroform extraction was repeated one more time and, finally, the clear aqueous phase containing the sugar derivatives was carefully collected and filtered for HPLC use. 2 . 8 . Acid hydrolysis of glycoprotein and glycopeptides In order to analyse the sugar composition of the histidine-tagged cPrx as a whole or the sugar composition of its individual glycans, cPrx or its glycans were hydrolysed to their individual monosaccharides. Glycoprotein 4 mg or gly- copeptides 2 mg from the HPLC separation were dissolved in 100 ml of HPLC grade distilled water in a Pierce Reacti-vial 1 × 3 cm, and 100 ml of 4 M TFA was added to give a final concentration of 2 M TFA. The vial was capped tightly, vortexed briefly and placed in a heating block Fisher Scien- tific at 100°C for 6 h [25]. The hydrolysate was cooled to room temperature and dried completely using a vacuum dessicator. For the derivatization of glycoprotein or gly- copeptide hydrolysate, the hydrolysates obtained from acid hydrolysis was dissolved in 20 ml of 40 mM lactose, and 80 ml of ABEE reagent was added. Other procedures were the same as the derivatization of standard sugars as described above, and the samples containing the sugar derivatives were also analyzed by HPLC. 2 . 9 . Re6erse phase HPLC analysis of the sugar deri6ati6es and construction of calibration cur6es for quantitati6e analysis The samples of ABEE sugar derivatives in the aqueous phase were subjected to HPLC C-18 column for sugar analysis using a 20-ml sample loop. The chromatography was performed at room temperature in an isocratic mode with 86 solvent A 50 mM sodium acetate buffer, pH 4.5 and 14 solvent B 50 mM sodium acetate buffer, pH 4.5acetonitrilemethanol = 404020, vvv at a flow rate of 2.4 mlmin for 60 min. The sugar derivatives were detected at 254 nm [19]. To set up standard curves, a range of standard sugars, Man, Gal, GlcNAc, Xyl, Fuc, from 200 to 800 nmol in 20-ml solutions containing 800 nmol of lactose as an internal standard, were derivatized with ABEE reagent, respectively, and 5 20 ml of the derivatives was analyzed using HPLC as described above.

3. Results